CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Looking for ways teens can make cash fast? Here are some quick ideas to help you start earning money today.
28,072 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Traders worldwide can compete in a two-week sprint using Leveraged's Sprint accounts. The top performers will face of...
London-listed Satsuma Technology is voting to sell its entire Bitcoin stash and delist, a decision that hinges on a J...
A new study ties ethical leadership to stronger profits, showing that business, nice guys finish when firms prioritiz...
NVIDIA stock sits at a crossroads as AI-driven demand and hyperscale spending shape a potential move toward $300. Ana...
SpaceX plans a $135-per-share IPO that could push its value to $1.77 trillion, potentially the largest U.S. listing e...
Coherent is set to join the S&P 500 on March 23, 2026, triggering automatic purchases by index funds. The move follow...
Former President Donald Trump announced a plan to codify a future-proof digital asset market framework, signaling a m...
New leadership at CMLS faces a fractured MLS landscape as mortgage markets and digital portals reshape U.S. housing f...
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
The insurance backdrop is stabilizing in mid-2026, but homeowners coverage costs stay stubbornly high. Builders and l...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...